Baird W M, Lau H H, Schmerold I, Coffing S L, Brozich S L, Lee H, Harvey R G
Department of Medicinal Chemistry and Pharmacognosy, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, IN 47907.
IARC Sci Publ. 1993(124):217-26.
The wide range of carcinogenic activities of optical isomers of bay-region diol-epoxides of polycyclic aromatic hydrocarbons (PAHs) demands analytical techniques capable of distinguishing both the diastereoisomer and enantiomers of the PAH diol-epoxide (PAH-DE) responsible for DNA adduct formation. Our laboratory recently developed postlabelling procedures using the radioisotope 35S for HPLC analysis of benzo[a]pyrene (BaP)-DNA adducts formed in BaP-treated hamster cell cultures. To allow identification and complete separation of anti-PAH-DE-DNA adducts from syn-PAH-DE-DNA adducts, an immobilized boronate chromatography procedure was developed using a high-capacity boronate column. Analysis of 7,12-dimethyl-benz[a]anthracene (DMBA)-DNA adducts formed in treated hamster embryo cells by this boronate chromatography procedure and 35S-postlabelling demonstrated that both anti- and syn-DMBA-DE were bound to DNA. These analytical techniques also provided evidence that the potent carcinogen and environmental PAH dibenzo[a,l]pyrene was metabolized in cells to a DNA-binding intermediate with structural characteristics of an anti-PAH-DE. Conditions were also developed for using 33P-labelled ATP in the postlabelling assay. The use of [33P] instead of [35S]ATP offers the advantages of ease of labelling and greater sensitivity while still using a weak beta-emitter. The development of PAH-DNA adduct analysis techniques with improved sensitivity allows more detailed studies of how PAHs interact with DNA and how this leads to cancer induction.
多环芳烃(PAHs)湾区二醇环氧化物的光学异构体具有广泛的致癌活性,这就需要能够区分导致DNA加合物形成的PAH二醇环氧化物(PAH-DE)的非对映异构体和对映异构体的分析技术。我们实验室最近开发了一种后标记程序,使用放射性同位素35S对苯并[a]芘(BaP)处理的仓鼠细胞培养物中形成的BaP-DNA加合物进行HPLC分析。为了从顺式PAH-DE-DNA加合物中鉴定并完全分离反式PAH-DE-DNA加合物,利用高容量硼酸酯柱开发了一种固定化硼酸酯色谱程序。通过这种硼酸酯色谱程序和35S后标记分析处理过的仓鼠胚胎细胞中形成的7,12-二甲基苯并[a]蒽(DMBA)-DNA加合物,结果表明反式和顺式DMBA-DE均与DNA结合。这些分析技术还提供了证据,表明强效致癌物和环境PAH二苯并[a,l]芘在细胞中代谢为具有反式PAH-DE结构特征的DNA结合中间体。还开发了在后标记测定中使用33P标记的ATP的条件。使用[33P]而不是[35S]ATP具有标记简便和灵敏度更高的优点,同时仍使用弱β发射体。灵敏度更高的PAH-DNA加合物分析技术的开发,使得能够更详细地研究PAHs如何与DNA相互作用以及这如何导致癌症诱导。